The founder and CEO of FTSE 250 constituent Oxford Nanopore Technologies has revealed that he will s...
In a post-pandemic world, international healthcare has entered a new era. Medical tourism is no long...
London-based startup Sava Technologies has raised £14.2m in Series A funding following promising ea...
MedTech Centauri Therapeutics has received an extra £3.8m in funding from CARB-X to develop its lea...
Listed MedTech Avacta Therapeutics has sold Coris Bioconcept SRL to 3B BlackBio Dx for an upfront fe...
A London-based MedTech developing vaccines against life threatening respiratory viral infections has...
FTSE 250 constituent Oxford Nanopore Technologies plc has released positive results for the first ha...
A Surrey-based listed MedTech has undergone a leadership shake up after its CEO and chairman both ag...
The entrepreneur behind the £100m exit of OXGENE in 2021 has secured funding for his next venture. ...
Newcastle’s AMLo Biosciences has crashed into administration. The life sciences company, which ...
An Italian venture capital firm with several UK DeepTech investments under its belt already is targe...
A leading MedTech expert has issued a stark warning about the risks posed to patient safety and data...